Gemmer Asset Management’s Anixa Biosciences ANIX Stock Holding History

Gemmer Asset Management’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$103K	Hold	35,000	–	–	0.01%	189
2026 Q2	$98K	Hold	35,000	–	–	0.01%	187
2026 Q1	$90.3K	Hold	35,000	–	–	0.01%	172
2025 Q4	$109K	Hold	35,000	–	–	0.01%	169
2025 Q3	$116K	Hold	35,000	–	–	0.01%	169
2025 Q2	$116K	Hold	35,000	–	–	0.01%	165
2025 Q1	$100K	Hold	35,000	–	–	0.01%	155
2024 Q4	$81.2K	Hold	35,000	–	–	0.01%	151
2024 Q3	$110K	Hold	35,000	–	–	0.01%	148
2024 Q2	$77.4K	Hold	35,000	–	–	0.01%	139
2024 Q1	$109K	Hold	35,000	–	–	0.01%	131
2023 Q4	$136K	Hold	35,000	–	–	0.02%	127
2023 Q3	$114K	Hold	35,000	–	–	0.02%	124
2023 Q2	$112K	Hold	35,000	–	–	0.02%	124
2023 Q1	$150K	Hold	35,000	–	–	0.02%	122
2022 Q4	$149K	Hold	35,000	–	–	0.02%	114
2022 Q3	$172K	Hold	35,000	–	–	0.03%	114
2022 Q2	$107K	Buy	+35,000	New	+$110K	0.02%	108

Other funds holding ANIX

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

First Affirmative Financial Network Colorado Springs, Colorado $456M AUM

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return

Continuum Wealth Advisors Saratoga Springs, New York $307M AUM 19.33% 1-Year Est. Return

Simplicity Wealth Summit, New Jersey $3.43B AUM 16.22% 1-Year Est. Return

Cherry Creek Investment Advisors Englewood, Colorado $261M AUM 29.65% 1-Year Est. Return

DeDora Capital Napa, California $448M AUM 15.92% 1-Year Est. Return

Livelsberger Financial Advisory Ashland, Ohio $18.6M AUM

Gemmer Asset Management's ANIX Position: Q3 2026 in Review

Gemmer Asset Management held its Anixa Biosciences (ANIX) position steady in Q3 2026 at 35,000 shares worth $103K. The position accounts for 0.01% of the portfolio, ranked #189.

Gemmer Asset Management first reported a position in ANIX in Q2 2022 and has held it in 18 quarters since. The position peaked at $172K in Q3 2022. 16 funds tracked by Wall St. Rank hold ANIX as of Q3 2026.

Gemmer Asset Management held 35,000 shares of Anixa Biosciences worth $103K as of Q3 2026.
Gemmer Asset Management left its Anixa Biosciences share count unchanged in Q3 2026.
Anixa Biosciences made up 0.01% of Gemmer Asset Management's portfolio in Q3 2026, its #189 holding.
Gemmer Asset Management first reported a position in Anixa Biosciences in Q2 2022 and has held it in 18 quarters since.
Gemmer Asset Management's Anixa Biosciences position peaked at $172K in Q3 2022.
16 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2026.

Based on Gemmer Asset Management's 13F filing for Q3 2026, filed 16 Oct 2026.